Cytotoxic effects of Agrimonia eupatoria L. against cancer cell lines in vitro  by Ad’hiah, Ali H. et al.
Journal of the Association of Arab Universities for Basic and Applied Sciences (2013) 14, 87–92University of Bahrain
Journal of the Association of Arab Universities for
Basic and Applied Sciences
www.elsevier.com/locate/jaaubas
www.sciencedirect.comORIGINAL ARTICLECytotoxic eﬀects of Agrimonia eupatoria L. against
cancer cell lines in vitroAli H. Ad’hiah a, Orooba N.H. Al-Bederi b, Khulood W. Al-Sammarrae c,*a Tropical-Biological Research Unit, College of Science, University of Baghdad, Baghdad, Iraq
b Biotechnology Department, College of Science, Al-Nahrain University, Baghdad, Iraq
c College of Science, Al-Nahrain University, Baghdad, IraqReceived 24 March 2012; revised 12 November 2012; accepted 5 January 2013







Cancer cell linesCorresponding author.
-mail address: prof_khulood
er review under responsibilit
Production an





as.2013.0Abstract The study was conducted to evaluate anti-tumor (human cervical cancer; HeLa and
Rhabdomyosarcoma; RD cell lines and a primary cell culture; mouse embryo ﬁbroblast; MEF)
potentials of Agrimonia eupatoria L. extracts (aqueous and methanol). Five concentrations (6.0,
12.0, 24.0, 48.0 and 96.0 lg/ml) of each plant extract were assessed through either three incubation
time periods (24, 48 and 72 h) for HeLa and RD cell lines, or one incubation time period (48 h) for
MEF cells. The results revealed that the ﬁve concentrations of plant extracts showed anti-tumor
properties in a concentration-dependent manner, and the methanol extract recorded better values
of percentage of growth inhibition (PGI) than aqueous extract in HeLa and RD cell lines, while,
less PGI values were recorded in the MEF cells. Among these concentrations, 96.0 lg/ml was the
most effective in producing PGI in RD and HeLa cancer cell lines for the three investigated time
periods.
ª 2013 University of Bahrain. Production and hosting by Elsevier B.V. All rights reserved.1. Introduction
Herbal medicines derived from plants are being increasingly
utilized to treat a wide variety of diseases in folkloric medicine
and accordingly, interest in pharmacological evaluation of var-
ious plants shows a progress worldwide, although a little
knowledge is available about their mechanism of actionil.com (K.W. Al-Sammarrae).
ersity of Bahrain.
g by Elsevier
. Production and hosting by Elsev
1.003(Gupta et al., 2004). Agrimonia eupatoria (Rose Family:
Rosaceae) is a further interest of medicinal plants. The plant
is known as agrimony in the English literature, and it is used
in folkloric medicine to treat a wide range of ailments; for in-
stance, eye infections, diarrhea and disorders of gall bladder,
liver and kidneys (Duke, 2002). However, experimental studies
have demonstrated several other biological and pharmaceuti-
cal potentials; for instance, anti-mutagenic and anti-tumor
(Horikawa et al., 1994), hepatoprotective (Park et al., 2004),
anti-viral (Kwon et al., 2005), anti-bacterial (Bae and Sohn,
2005) and anti-oxidant and anti-inﬂammatory (Correia et al.,
2007) effects. This is reasoned by the fact that A. eupatoria is
rich in chemical constituents (ﬂavonoids, tannins, aromatic
acids, triterpenes, coumarins, terpenoids, glycosides, and vita-
mins B and K) that can mediate such potentials (Xu et al.,
2005).ier B.V. All rights reserved.
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Koshiura et al. (1985) was the ﬁrst who investigated the
anti-tumor activity of another species (Agrimonia pilosa).
In this study, effects of a methanol extract from roots of
the plant on several transplantable rodent tumors were eval-
uated. Their results indicated that the roots of the plant con-
tain some anti-tumor constituents, and they also suggested
that the possible mechanisms of the anti-tumor activity
may be related to some host-mediated actions and/or a di-
rect cytotoxicity. Based on such ﬁnding, Miyamoto et al.
(1988) investigated the effect of agrimoniin, a tannin con-
tained in A. pilosa, on ascites type and solid type rodent tu-
mors. Their results indicated that agrimoniin is a potent
anti-tumor tannin and they suggested that the anti-tumor ef-
fect may be due to this tannin, which can enhance the im-
mune response of the host animals through the actions on
tumor cells and some cells of the immune system. In 1992,
it was found that agrimoniin is able to induce interleukin
(IL)-1 production in vitro (human peripheral blood mononu-
clear cells) and in vivo (mouse adherent peritoneal exudate
cells), and accordingly the anti-tumor effects can be justiﬁed
(Murayama et al., 1992). Anti-mutagenic and anti-carcino-
genic effects of A. pilosa were further conﬁrmed in vitro
against the environmental mutagens and carcinogens ben-
zo[a]pyrene, 1,6-dinitropyrene and 3,9-dinitroﬂuoranthene
(Horikawa et al., 1994).
As presented, studies have been engaged in assessing the
potentials of A. pilosa, while A. eupatoria has not been investi-
gated extensively; therefore the present investigation came to
evaluate cytotoxic effects of A. eupatoria aqueous and metha-
nol extracts in vitro against two cancer cell lines (Human rhab-
domyosarcoma; RD and human cervical cancer; HeLa) and a
primary cell culture (mice embryo ﬁbroblast; MEF).
2. Materials and methods
2.1. Plant collection and identiﬁcation
The plant taxonomist Professor Dr. Ali Al-Mosawy (Depart-
ment of Biology, College of Science, University of Baghdad)
identiﬁed the plant A. eupatoria, which was collected in July
2008 from mountain regions (Binqulat village) surrounding
the city of Erbil (around 400 km North the capital Baghdad).
2.2. Extraction
Dried aerial parts of A. eupatoria (leaves, stem and ﬂowers)
were powdered using a coffee grinder for 5 min, and then ex-
tracted with two types of solvents (distilled water or metha-
nol). In both cases, 50 grams of the processed plant was
extracted in 250 ml of the solvent using the Soxhlet apparatus
and the source of heating was a warm water bath (45 C). The
obtained extract solution was then evaporated at 45 C using a
rotary evaporator, and the resultant crude extract was frozen
at 20 C until use to prepare the required concentrations
(Arokiyaraj et al., 2007).
2.3. Cancer cell lines and normal cells
RD cell line was on passage number 195, while HeLa cell line
was on passage number 185. Both cell lines were supplied byAl-Nahrain Research Centre (Al-Nahrain University), while
MEF cells were prepared from a pregnant mouse at a gestation
period of 11–13 days, following the instructions of Freshney
(2000).
2.4. Growth inhibition assessment
Laboratory assessment of growth inhibition was carried out
according to a method presented by Freshney (2001). The
cells were supplemented as monolayer attached cells in
Falcon culture ﬂasks (25 ml) containing RPMI-1640 med-
ium (Sigma, USA). The cells were washed with PBS, and
then 1 ml of trypsin–versene solution (Sigma, USA; BDH,
England) was added with a gentle shaking until cells were
detached from the ﬂask surface. Such manipulation was
carried out with the aid of a phase contrast inverted micro-
scope. Then, the contents of the ﬂask were transferred to
another ﬂask and incubated at 37 C (supplemented with
5% CO2) for 15 min (sub-culture), and then cell number
was adjusted to 1 · 106 cell/ml. At the same time, viability
was assessed using a dye-exclusion test (trypan blue stain;
Pharmacia ﬁne chemical, Sweden), and it was always great-
er than 96%. Such cells were seeded in wells of a 96-well
tissue culture plate, and the plate was incubated overnight
at 37 C (supplemented with 5% CO2). The day after, the
wells were examined to inspect the formation of a cell
monolayer, and then ﬁve concentrations (6.0, 12.0, 24.0,
48.0 and 96.0 lg/ml) of each plant extract were prepared
and the solvent was RPMI-1640 medium. In the case of
methanol extract, it was ﬁrst dissolved in drops of DMSO,
and then the volume was made-up with RPMI-1640 med-
ium. Both extract solutions were ﬁlter-sterilized (0.22 lm
Millipore ﬁlter). In each well, 50 ll of each concentration
was pipetted and the plate was wrapped with a cling ﬁlm
and incubated at 37 C (supplemented with 5% CO2). In
this regard three plates were prepared to cover three incu-
bation time periods; 24, 48 and 72 h, except MEF cells, in
which the incubation period was 48 h. After the end of
each incubation time period, the medium in each well
was discarded and wells were washed once with PBS, and
then 0.8 ml of neutral red solution (Sigma, USA) was
added to each well. The plate was re-incubated at 37 C
for 2 h. After incubation, neutral red solution was dis-
carded and each well was washed once with PBS, and in
each well, 0.1 ml of phosphate buffered-ethanol (0.1 M
NaH2PO4-ethanol; 1:1) was added. The wells were read
using ELISA reader at a wave length of 492 nm, and
absorbance was recorded. Percentage of growth inhibition
(PGI) of the tested materials was calculated using the fol-
lowing equation:




For each evaluation, the mean of three observations was ob-
tained and differences between means were assessed by least
signiﬁcant difference (LSD) and Duncan test, using the statis-
tical package SPSS version 13.0. The difference was considered
signiﬁcant when probability (P) 6 0.05.
Table 1 Growth inhibition effects of Agrimonia eupatoria aqueous extract on RD and HeLa cell lines after 24 h incubation.
Extract concentration (lg/ml) Percentage of growth inhibition (Mean ± SE)* LSD probability
RD cell line HeLa cell line
6 15.07 ± 0.43a 20.97 ± 0.24a Not signiﬁcant
12 21.37 ± 1.72b 26.70 ± 0.40b Not signiﬁcant
24 23.80 ± 4.33b 27.25 ± 2.63b Not signiﬁcant
48 23.97 ± 4.33b 33.03 ± 0.88c 0.007
96 35.77 ± 6.04c 33.37 ± 1.92c Not signiﬁcant
* Different letters: signiﬁcant difference (P 6 0.5) between means of the columns.
Table 2 Growth inhibition effects of Agrimonia eupatoria aqueous extract on RD and HeLa cell lines after 48 h incubation.
Extract concentration (lg/ml) Percentage of growth inhibition (Mean ± SE)* LSD probability
RD cell line HeLa cell line
6 42.00 ± 4.61a 36.33 ± 2.67a Not signiﬁcant
12 42.00 ± 4.61a 53.33 ± 2.67a Not signiﬁcant
24 53.00 ± 3.00b 53.33 ± 2.67a Not signiﬁcant
48 53.00 ± 3.00b 59.67 ± 3.00b Not signiﬁcant
96 67.00 ± 9.81c 72.67 ± 16.33c Not signiﬁcant
* Different letters: signiﬁcant difference (P 6 0.5) between means of the columns.
Table 3 Growth inhibition effects of Agrimonia eupatoria aqueous extract on RD and HeLa cell lines after 72 h incubation.
Extract concentration (lg/ml) Percentage of growth inhibition (Mean ± SE)* LSD probability
RD cell line HeLa cell line
6 57.33 ± 1.20a 60.00 ± 0.58a Not signiﬁcant
12 58.67 ± 0.33a 65.67 ± 0.67b Not signiﬁcant
24 60.33 ± 1.45a 69.00 ± 0.58c 0.026
48 70.00 ± 1.53b 75.33 ± 0.67d Not signiﬁcant
96 73.00 ± 0.58b 84.00 ± 0.58e Not signiﬁcant
* Different letters: signiﬁcant difference (P 6 0.5) between means of the columns.
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3.1. Aqueous extract (24 h of incubation)
There was a gradual increase in the value of PGI as the concen-
tration of the extract was increased (15.07, 21.37, 23.80, 23.97
and 35.77% for the concentrations 6.0, 12.0, 24.0, 48.0 and
96.0 lg/ml, respectively) against RD cells. The 1st and 5th con-
centrations showed a signiﬁcant difference (P 6 0.05) in com-
parison with the 2nd, 3rd and 4th concentrations, and the
latter concentrations showed no signiﬁcant differences between
them. A similar observation was made in HeLa cells, but the
4th concentration showed a signiﬁcant difference (P 6 0.05)
in comparison with the 1st, 2nd and 3rd concentrations. This
concentration also showed a signiﬁcant difference
(P= 0.007) in the PGI value when a comparison was made be-
tween HeLa (33.03%) and RD (23.97%) cells (Table 1).
3.2. Aqueous extract (48 h of incubation)
The ﬁve concentrations of aqueous extract were effective in
reducing the growth of both cell lines, and almost the effect
was similar (no signiﬁcant differences between them) on RD
and HeLa cells. The effect was concentration-dependent, and
accordingly the 5th concentration recorded the highest PGI,which was 67% in RD cells and 72% in HeLa cells. These
two values were signiﬁcantly different (P 6 0.05) in compari-
son with PGI values of the other concentrations of the same
cell line (Table 2).
3.3. Aqueous extract (72 h of incubation)
Much more growth reducing effects were observed after 72 h of
incubation, and the 5th concentration was the most efﬁcient on
both cell lines, in which no signiﬁcant differences were recorded
between them in all concentrations, with the exception of 24 lg/
ml, which showed a signiﬁcantly (P = 0.026) higher PGI in
HeLa cells (69%) than the PGI in RD cells (60.33%) (Table 3).
3.4. Methanol extract (24 h of incubation)
The ﬁrst four concentrations recorded a PGI range of 13–
25.33% in RD cell line, while such range in HeLa cell line
was 14.00–30.67%. The range exceeded dramatically at the
5th concentration (96 lg/ml), but the PGI in RD cell line
was signiﬁcantly (P= 0.001) higher than that of HeLa cell line
(80.00% vs. 53.67%). A further signiﬁcant difference
(P= 0.013) was observed at the concentration of 12 lg/ml,
in which the PGI in RD cell line was higher than that of HeLa
cell line (25% vs. 16%) (Table 4).
Table 4 Growth inhibition effects of Agrimonia eupatoria methanol extract on RD and HeLa cell lines after 24 h incubation.
Extract concentration(lg/ml) Percentage of growth inhibition (Mean ± SE)* LSD probability
RD cell line HeLa cell line
6 13.00 ± 1.00a 14.00 ± 1.15a Not signiﬁcant
12 25.00 ± 0.58b 16.67 ± 0.67a 0.013
24 24.00 ± 0.57b 27.67 ± 1.45b Not signiﬁcant
48 25.33 ± 0.33b 30.67 ± 3.67b Not signiﬁcant
96 80.00 ± 0.58c 53.67 ± 0.67c 0.001
* Different letters: signiﬁcant difference (P 6 0.5) between means of the columns.
Table 5 Growth inhibition effects of Agrimonia eupatoria methanol extract on RD and HeLa cell lines after 48 h incubation.
Extract concentration(lg/ml) Percentage of growth inhibition (Mean ± SE)* LSD probability
RD cell line HeLa cell line
6 24.00 ± 2.00a 27.33 ± 1.45a Not signiﬁcant
12 27.33 ± 4.70a 33.67 ± 3.38a Not signiﬁcant
24 32.67 ± 0.66a 34.67 ± 6.56a Not signiﬁcant
48 36.67 ± 1.67b 36.67 ± 5.90b Not signiﬁcant
96 82.00 ± 1.00c 84.00 ± 1.00c Not signiﬁcant
* Different letters: signiﬁcant difference (P 6 0.5) between means of the columns.
Table 6 Growth inhibition effects of Agrimonia eupatoria methanol extract on RD and HeLa cell lines after 72 h incubation.
Extract concentration(lg/ml) Percentage of growth inhibition (Mean ± SE)* LSD probability
RD cell line HeLa cell line
6 13.50 ± 0.29a 58.00 ± 7.94a 0.001
12 27.00 ± 2.08b 62.00 ± 6.56b 0.001
24 30.33 ± 0.67b 63.00 ± 2.00b 0.001
48 33.00 ± 1.00b 65.00 ± 1.00b 0.001
96 90.00 ± 3.05c 87.00 ± 2.65c Not signiﬁcant
* Different letters: signiﬁcant difference (P 6 0.5) between means of the columns.
Table 7 Growth inhibition effects of Agrimonia eupatoria extracts (aqueous and methanol) on MEF cell line after 48 h incubation.
Extract concentration (lg/ml) Percentage of growth inhibition (Mean ± SE)* LSD probability
Aqueous extract Methanol extract
6 14.80 ± 0.72a 16.50 ± 1.44a Not signiﬁcant
12 10.90 ± 1.30b 15.63 ± 0.73a 0.01
24 12.40 ± 1.56ab 12.70 ± 1.24b Not signiﬁcant
48 13.00 ± 1.53a 14.13 ± 2.92ab Not signiﬁcant
96 14.00 ± 1.15a 10.53 ± 0.74b 0.01
* Different letters: signiﬁcant difference (P 6 0.5) between means of the columns.
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Approximated values of PGI were recorded in the ﬁve tested
concentrations for both cell lines, especially the 5th
concentration in which the PGI was 82% and 84% for RD
and HeLa cell lines, respectively (Table 5).
3.6. Methanol extract (72 h of incubation)
Again the 5th concentration recorded the highest PGI in RD
and HeLa cell lines (90% and 87%, respectively) with no sig-niﬁcant difference between them. However, the ﬁrst four con-
centrations contradicted such scope, in which the PGI
recorded signiﬁcantly (P= 0.001) higher values in HeLa cells
than in RD cells (Table 6).
3.7. Mouse embryonic ﬁbroblast (MEF) Cell
The aqueous and methanol extracts recorded an approximated
range of PGI against MEF cells (aqueous extract: 10.90–
14.80%; methanol extract: 10.53–16.58%) with the exception
of the concentration 12 lg/ml, in which the methanol extract
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pared with the PGI of the corresponding aqueous extract con-
centration (15.63% vs. 10.90%) (Table 7).
4. Discussion
The two extracts of A. eupatoria showed in vitro growth inhi-
bition effects on the two cancer cell lines (RD and HeLa),
while there was no effect on the growth on normal cells
(MEF). Such selective effects were concentration-, as well as,
incubation time period-dependent. With respect to concentra-
tion, the ﬁve assessed concentrations (6.0, 12.0, 24.0, 48.0 and
96.0 lg/ml) of each extract were evaluated after running preli-
minary assessments to determine the initial effective concentra-
tion. The start was with 1.0, 2.0 and 3.0 lg/ml, but they
showed no effective growth inhibition against RD and HeLa
cell lines or MEF cells. Therefore, ﬁve serial duplications of
the third concentration were investigated. Among these con-
centrations, 96.0 lg/ml was the most effective in producing
PGI in RD and HeLa cancer cell lines for the three investi-
gated time periods. Such anti-proliferation effects can be justi-
ﬁed in the ground of the extract chemical constituents.
Chemical analysis (data not shown) of A. eupatoria extracts
(aqueous and methanol) revealed that the plant was positive
for several secondary metabolites. Both aqueous and methanol
extracts were positive for ﬂavonoids, alkaloids, tannins and
glycosides and negative for saponins. Flavonoids were further
identiﬁed by thin layer chromatography (TLC), and as sug-
gested by RF values of the separated extracts, the aqueous ex-
tract contained myricetin, azoleatin, vitexin and isoorientin,
while the methanol extract contained kaempferol, quercetin,
isorhamnetin and myricetin.
Flavonoid and tannin contents of the two extracts may be
served as good anti-cancer agents (Huang et al., 2010). The
mechanism of such anti-cancer cytotoxicity is not well under-
stood, but the anti-oxidant potential of the two chemical con-
stituents cannot be ignored (Russo et al., 2005), although the
correlation between their anti-oxidative and anti-carcinogenic
activities remains unclear (Tomisato et al., 2007). Among poly-
phenols is the tannin compound epigallocatechin-3-gallate,
which has been demonstrated to possess anti-oxidative activity
and to induce apoptosis in tumor cells (Chen et al., 2009). The
apoptosis was found to occur through two main pathways; in
the ﬁrst death receptors are triggered, while the second path-
way involves an intrinsic mitochondrial damage, which results
in the release of cytochrome C and activation of caspase-9
(Gosse et al., 2005). Furthermore, polyphenolics can cause a
down-regulation of factors that are necessary for cell-cycle
progression, and this series of events lead to stoppage of cell
cycle progression at the G1-S phase transition and thereby
causing G0/G1 arrest and subsequent apoptotic cell death (Cil-
la et al., 2009). Accordingly, natural polyphenols have gained a
great interest in pharmaceutical industry due to their demon-
strated inhibitory activity against tumorigenesis, and a com-
parative study of Hakimuddin et al. (2008) proposed that
total polyphenolics isolated from wine were more effective in
reducing tumor growth as compared with a hydrophobic poly-
phenolic fraction isolated from the wine. Analyses of gene
expression showed that genes belonging to signaling pathways
were down-regulated in the induced tumor of grape polyphe-
nol-treated mice.Flavonoids are a further constituent of A. eupatoria extracts
that might have exerted anti-tumor effects, and a study carried
out by Aherne and O’Brien (2000) showed that ﬂavonoids
from different fruits and vegetables were capable to modulate
H2O2-induced DNA damage in two cell line models (colon car-
cinoma and hepatic cell carcinoma). In agreement with such
ﬁnding, it has been demonstrated that ﬂavonoids are acting
as a scavenging system, in addition to their role in arresting
the DNA replication in S phase, and inducing apoptosis due
to the inactivation of BCL-2 gene as reported in different types
of leukemias (Pellecchia and Reed, 2004). Furthermore, it has
been suggested that polyphenolic fractions may affect the
topological state of the DNA by increasing or decreasing the
level of cleavage of DNA topoisomerases, especially DNA
topoisomerase II; causing DNA topoisomerase II poisoning
(Gonzalez de Mejia et al., 2006). The DNA topoisomerase II
is a ubiquitous enzyme that regulates DNA unwinding and re-
moves knots and tangles from the genetic material by creating
transient breaks in the sugar phosphate back bone of the dou-
ble helix (Fortune and Osheroff, 2000). Topoisomerases also
maintain genomic integrity during this process by forming
covalent attachments between active site residues and terminal
DNA phosphates that are generated during the cleavage reac-
tion (Champoux, 2001).
In the present study, it was also demonstrated that both ex-
tracts exerted a selective effect against investigated cell lines
and normal cells, and in agreement with this ﬁnding, several
in vitro studies have demonstrated the selective tumoricidal ac-
tion of natural products, and the action occurred without
harming the normal cell (Grifﬁn et al., 2007); a ﬁnding which
was also observed in the present study against the MEF cells.
In this context, Weber (2009) demonstrated that the secondary
metabolite ﬂavonoids of Scutellaria were not only cytostatic
but also cytotoxic to various human tumor cell lines in vitro
and inhibit tumor growth in vivo, but most importantly, almost
no or minor toxicity of these ﬂavonoids against normal epithe-
lial and normal peripheral blood and myeloid cells was
observed.
In conclusion, the present plant extracts can be considered
as an important source of natural products that have anti-can-
cer potentials, but it is too early to reach a ﬁnal conclusion and
further investigations are required to include further cell lines.
Equally important, in vivo evaluation may certainly augment
such potentials.References
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